{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:35:19Z","timestamp":1789767319727,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/hjh.0b013e328351d380","type":"journal-article","created":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T04:17:49Z","timestamp":1330575469000},"page":"893-900","source":"Crossref","is-referenced-by-count":58,"title":["Impact of lower range of prehypertension on cardiovascular events in a general population"],"prefix":"10.1097","volume":"30","author":[{"given":"Masayo","family":"Fukuhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"The National High Blood Pressure Education Program Coordinating CommitteeSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R2-12-20210208","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease.","volume":"345","author":"Vasan","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-12-20210208","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/bmj.39269.672188.AE","article-title":"Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study.","volume":"335","author":"Conen","year":"2007","journal-title":"BMJ"},{"key":"R4-12-20210208","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.106.656850","article-title":"for the Womens Health Initiative InvestigatorsPrehypertension and cardiovascular disease risk in the Womens Health Initiative.","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation"},{"key":"R5-12-20210208","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/HJH.0b013e328330e882","article-title":"Impact of blood pressure levels on different types of stroke: the Hisayama Study.","volume":"27","author":"Arima","year":"2009","journal-title":"J Hypertens"},{"key":"R6-12-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ajh.2008.356","article-title":"Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study.","volume":"22","author":"Ikeda","year":"2009","journal-title":"Am J Hypertens"},{"key":"R7-12-20210208","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ajh.2008.335","article-title":"Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population: the Ohsaki Study.","volume":"22","author":"Hozawa","year":"2009","journal-title":"Am J Hypertens"},{"key":"R8-12-20210208","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)61199-5","article-title":"Premature deaths attributable to blood pressure in China: a prospective cohort study.","volume":"374","author":"He","year":"2009","journal-title":"Lancet"},{"key":"R9-12-20210208","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.107.743211","article-title":"Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population.","volume":"118","author":"Kubo","year":"2008","journal-title":"Circulation"},{"key":"R10-12-20210208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/BF00401066","article-title":"Prevalence of type 2 (noninsulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study.","volume":"36","author":"Ohmura","year":"1993","journal-title":"Diabetologia"},{"key":"R11-12-20210208","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/STROKEAHA.106.479642","article-title":"Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama Study.","volume":"38","author":"Ninomiya","year":"2007","journal-title":"Stroke"},{"key":"R12-12-20210208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/ATVBAHA.107.157164","article-title":"High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama Study.","volume":"28","author":"Arima","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-12-20210208","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/hr.2009.161","article-title":"Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama Study.","volume":"32","author":"Arima","year":"2009","journal-title":"Hypertens Res"},{"key":"R14-12-20210208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"R15-12-20210208","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/ndt\/gfq062","article-title":"Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study.","volume":"25","author":"Nagata","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R16-12-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10157-009-0163-9","article-title":"and Japanese Society of NephrologyCKD clinical practice guidebook. The essence of treatment for CKD patients.","volume":"13","author":"Ando","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"R17-12-20210208","first-page":"S1","article-title":"KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R18-12-20210208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2105\/AJPH.88.1.15","article-title":"Use and misuse of population attributable fractions.","volume":"88","author":"Rockhill","year":"1998","journal-title":"Am J Public Health"},{"key":"R19-12-20210208","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/oxfordjournals.aje.a009905","article-title":"Re: Confidence limits made easy: interval estimation using a substitution method.","volume":"149","author":"Greenland","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R20-12-20210208","first-page":"1859","article-title":"Is prehypertension a risk factor for cardiovascular diseases S","volume":"36","author":"Qureshi","year":"2005","journal-title":"troke"},{"key":"R21-12-20210208","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.108.772285","article-title":"Incidence and risk factors for stroke in American Indians: the Strong Heart Study.","volume":"118","author":"Zhang","year":"2008","journal-title":"Circulation"},{"key":"R22-12-20210208","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/HYPERTENSIONAHA.107.102459","article-title":"and the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN)Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies.","volume":"51","author":"Murakami","year":"2008","journal-title":"Hypertension"},{"key":"R23-12-20210208","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/HJH.0b013e32833a8b9f","article-title":"and the Jichi Medical School Cohort Investigators GroupPrehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study.","volume":"28","author":"Ishikawa","year":"2010","journal-title":"J Hypertens"},{"key":"R24-12-20210208","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HJH.0b013e32831967ca","article-title":"and the Japan Arteriosclerosis Longitudinal Study (JALS) groupStroke risk and antihypertensive drug treatment in the general population: the Japan Arteriosclerosis Longitudinal Study.","volume":"27","author":"Asayama","year":"2009","journal-title":"J Hypertens"},{"key":"R25-12-20210208","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/HYPERTENSIONAHA.108.118273","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita Study.","volume":"52","author":"Kokubo","year":"2008","journal-title":"Hypertension"},{"key":"R26-12-20210208","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2007010067","article-title":"Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study.","volume":"18","author":"Ninomiya","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R27-12-20210208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R28-12-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"on behalf of the Japanese Society of Hypertension CommitteeThe Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertens Res"},{"key":"R29-12-20210208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"R30-12-20210208","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"R31-12-20210208","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"R32-12-20210208","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.","volume":"370","year":"2007","journal-title":"Lancet"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201205000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:53Z","timestamp":1786048973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201205000-00012"}},"subtitle":["the Hisayama Study"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328351d380","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}